NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Novartis to manufacture CureVac’s Covid-19 vaccine candidate CVnCoV

By NS Healthcare Staff Writer 05 Mar 2021

Novartis will manufacture the mRNA and bulk drug product for up to 50 million doses of the CVnCoV vaccine candidate by end of 2021

Exscientia secures $100m in funding round backed by....

Exscientia intends to use proceeds from the financing round to further advance

FDA approves expanded use of Pfizer’s Lorbrena as....

The expanded approval is based on CROWN trial, which showed that treatment

FDB begins expansion of biologics production facility in....

FDB intends to create 300 new positions in Denmark by the end

Philips, DiA Imaging Analysis to automate ultrasound imaging

The partnership will integrate DiA Imaging’s AI applications with Philips’ ultrasound technology

Pharmaceuticals

Johnson & Johnson’s single-dose Covid-19 vaccine authorised in US
01 Mar 21

Takeda to divest four diabetes products in Japan for $1.2bn
26 Feb 21

Novartis to manufacture CureVac’s Covid-19 vaccine candidate CVnCoV

Exscientia secures $100m in funding round backed by....

FDA approves expanded use of Pfizer’s Lorbrena as....

FDB begins expansion of biologics production facility in....

Philips, DiA Imaging Analysis to automate ultrasound imaging

Pharmaceuticals

Johnson & Johnson’s single-dose Covid-19 vaccine authorised in US
01 Mar 21

Takeda to divest four diabetes products in Japan for $1.2bn
26 Feb 21

Pfizer, BioNTech start trial for third booster dose against new Covid-19 variants
26 Feb 21

Patient Care

Quidel gets FDA EUA for QuickVue at-home Covid-19 test
02 Mar 21

Memic’s Hominis surgical robotic system granted FDA De Novo authorisation
02 Mar 21

Roche gets special approval for its at-home SARS-CoV-2 rapid antigen test in Germany
01 Mar 21

Nutraceuticals

FDA warns ten companies for illegally selling dietary supplements
22 Feb 21

Abbott expands Pedialyte product line with four new formulations
15 Dec 20

Abbott introduces first infant formula similar to breast milk in Canada
18 Nov 20

NS Healthcare is using cookies

Johnson & Johnson’s single-dose Covid-19 vaccine authorised in US01 Mar 21

Takeda to divest four diabetes products in Japan for $1.2bn26 Feb 21

Pfizer, BioNTech start trial for third booster dose against new Covid-19 variants26 Feb 21

Quidel gets FDA EUA for QuickVue at-home Covid-19 test 02 Mar 21

Memic’s Hominis surgical robotic system granted FDA De Novo authorisation 02 Mar 21

Roche gets special approval for its at-home SARS-CoV-2 rapid antigen test in Germany 01 Mar 21

FDA warns ten companies for illegally selling dietary supplements22 Feb 21

Abbott expands Pedialyte product line with four new formulations15 Dec 20

Abbott introduces first infant formula similar to breast milk in Canada18 Nov 20

OUR TITLES

AGC Biologics to expand cell and....03 Mar 21

Lilly invests $30m in new capital....18 Jan 21

Taking connected healthcare to ‘the next....15 Jun 20

UK needs better PPE stockpiles for....12 Jun 20

ICON agrees to acquire PRA Health....25 Feb 21

Novartis’ Sandoz to acquire GSK’s cephalosporin....12 Feb 21

Horizon to acquire biotechnology firm Viela....02 Feb 21

Boston Scientific to acquire cardiac health....22 Jan 21

GSK, Vir expand collaboration to develop....18 Feb 21

AstraZeneca closes sale of Crestor rights....11 Feb 21

CureVac, UK Government partner to develop....08 Feb 21

Philips, Dutch SAZ hospital network partner....05 Feb 21

Johnson & Johnson’s single-dose Covid-19 vaccine authorised in US
01 Mar 21

Takeda to divest four diabetes products in Japan for $1.2bn
26 Feb 21

Pfizer, BioNTech start trial for third booster dose against new Covid-19 variants
26 Feb 21

Quidel gets FDA EUA for QuickVue at-home Covid-19 test
02 Mar 21

Memic’s Hominis surgical robotic system granted FDA De Novo authorisation
02 Mar 21

Roche gets special approval for its at-home SARS-CoV-2 rapid antigen test in Germany
01 Mar 21

FDA warns ten companies for illegally selling dietary supplements
22 Feb 21

Abbott expands Pedialyte product line with four new formulations
15 Dec 20

Abbott introduces first infant formula similar to breast milk in Canada
18 Nov 20

AGC Biologics to expand cell and....
03 Mar 21

Lilly invests $30m in new capital....
18 Jan 21

Taking connected healthcare to ‘the next....
15 Jun 20

UK needs better PPE stockpiles for....
12 Jun 20

ICON agrees to acquire PRA Health....
25 Feb 21

Novartis’ Sandoz to acquire GSK’s cephalosporin....
12 Feb 21

Horizon to acquire biotechnology firm Viela....
02 Feb 21

Boston Scientific to acquire cardiac health....
22 Jan 21

GSK, Vir expand collaboration to develop....
18 Feb 21

AstraZeneca closes sale of Crestor rights....
11 Feb 21

CureVac, UK Government partner to develop....
08 Feb 21

Philips, Dutch SAZ hospital network partner....
05 Feb 21